Pro Research: Wall Street dives into Regeneron's robust prospects
Regeneron (NASDAQ:REGN) Pharmaceuticals, Inc. remains at the forefront of the biopharmaceutical industry, with a strategic focus on novel therapeutic areas and a robust financial standing. Analysts from BMO Capital Markets, Morgan Stanley, and RBC Capital …